Investing Profile

Richard Gaster

InvestorVC

Managing Partner at venBio Partners

venbio.com/gaster.htmlSan Francisco, California

Your Intro Paths to Richard Gaster

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Richard is a member of

Stanford University Network

1349 CONNECTIONS

University of Pennsylvania Network

494 CONNECTIONS

Career Break Network

71 CONNECTIONS

Harvard Medical School Network

64 CONNECTIONS

Third Rock Ventures Network

52 CONNECTIONS

Find Richard Gaster on

Current Investing Position

venBio Partners Managing Partner

Investment Range

$20.0M - $30.0M

Sweet Spot

$25.0M

Investments On Record

Richard Gaster is on these Sector & Stage Rankings

Pharmaceuticals (Seed)BioTech (Series B)BioTech (Seed)Pharmaceuticals (Series B)BioTech (Series A)Pharmaceuticals (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay Area Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Richard Gaster's Investments On Record (11)

Company	StageDateRound Size	Total Raised
Oak hill bio	Series AJun 2026$33M	$33M
Aeovian Pharmaceuticals	Series BDec 2025$55M Series AOct 2019$37M	$140M
Co-investors: Jens Eckstein (Apollo Health Ventures), Themasap Khan (Luma Group), William Greene (MPM BioImpact), Viktoriya Tigipko (TA Ventures)
Alumis	Series CMar 2024$260M	$330M
Co-investors: Vikram Bajaj (Foresite Capital), Michael Rome (Foresite Capital), Jim Tananbaum (Foresite Capital Management)
Attralus	Series BFeb 2024$56M Series BSep 2021$120M Series ASep 2020$25M	$200M
Pharvaris	Post Ipo EquityJun 2023$70M Series CNov 2020$80M Series BSep 2019$66M	$220M
Co-investors: Brett Zbar (General Atlantic)
Entact Bio	Series ADec 2022$81M	$81M
Co-investors: Andrew Sinclair (Abingworth), Owen Smith (4BIO Capital)
ACELYRIN	Series CSep 2022$300M Series BNov 2021$250M	$560M
Co-investors: Beth Seidenberg (Kleiner Perkins), Dan Becker (Access Industries), Sean Harper
ImmPACT Bio	Series BJan 2022$140M	$140M
Co-investors: Jim Tananbaum (Foresite Capital Management), Yvonne Yamanaka (venBio Partners), Cindy Xiong (Venrock)

Richard Gaster's Experience

Board Member Entact Bio2021 - Present

Board Member Attralus2020 - Present

Board Member NorthSea Therapeutics B.V.2020 - Present

Board Member Aeovian Pharmaceuticals2019 - Present

Board Observer Swift Health Systems Inc.2019 - Present

Board Member Arrakis Therapeutics2019 - Present

Managing Partner venBio Partners2017 - Present

Board Member Career BreakPresent

Board Member AlumisPresent

Board Observer Yarrow BiosciencePresent

Board Member Pediatric Brain Tumor FoundationPresent

Board Member Oak hill bioPresent

Managing Partner venBioPresent

Board Member 35Pharma2022 - 2026

Board Member ACELYRIN, INC.2021 - 2023

Board Member Ventyx Biosciences2021 - 2023

Board Member Pharvaris2019 - 2021

Board Observer Harmony Biosciences2017 - 2020

Board Observer Akero Therapeutics2018 - 2019

Head of Translational Medicine Pliant Therapeutics2016 - 2017

Senior Associate Third Rock Ventures2015 - 2016

Founder & Inventor wearBiō2013 - 2016

Richard Gaster's Education

Harvard Medical School Plastic and Reconstructive Surgery Resident Physician

Stanford University School of Medicine Doctor of Medicine (M.D.), Medical Scientist Training Program (MSTP)

Stanford University Doctor of Philosophy (Ph.D.) Bioengineering

University of Pennsylvania BSE Bioengineering

Stanford University School of Medicine BSE Bioengineering

Stanford University School of Medicine Doctor of Medicine (M.D.) Medical Scientist Training Program (MSTP)

Buckley

Investors who invest with Richard Gaster

Scouts & Angels Affiliated With Richard Gaster